Livzon Rapid Test for SARS-CoV-2 Antigen (Lateral Flow) Livzon Rapid Test for SARS-CoV-2 Antigen (Lateral Flow) is used for in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal swabs, oropharyngeal swabs and nasal swabs from individuals who are suspected of SARS-CoV-2 by their healthcare provider within the first seven days of symptom onset.
The novel Antigen Rapid Test swab is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in Nasopharyngeal swab and Oropharyngeal swab using the rapid method with a reading result in 10-15 minutes.
